{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:33:57Z","timestamp":1780374837174,"version":"3.54.1"},"reference-count":32,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T00:00:00Z","timestamp":1637625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Background: Hepatic injury secondary to congestive heart failure is well described, however, only limited data exist about the possible impact of acute cardiac dysfunction on the liver. We aimed to explore the possible cardio-hepatic interaction in patients with myocardial infarction. Material and methods: A single-center retrospective cohort study of 1339 ST elevation myocardial infarction (STEMI) patients who underwent primary coronary intervention between June 2012 to June 2019. Echocardiographic examinations were performed to assess left ventricular ejection fraction (LVEF) and central venous pressure (CVP). Patients were stratified into four groups by their LVEF and CVP levels: LVEF \u2265 45%, and CVP \u2264 10 mm\/Hg (n = 853), LVEF &lt; 45% with CVP \u2264 10 mm\/Hg (n = 364), EF \u2265 45%, with CVP &gt; 10 mm\/Hg (n = 61), and LVEF &lt; 45% with CVP &gt; 10 mm\/Hg (n = 61). Patients were evaluated for baseline and peak liver enzymes including alanine transaminase (AST), alanine aminotransferase (ALT), gamma glutamyl transferase (GGT), alkaline phosphatase (ALP), and bilirubin. Results: Greater severity of cardiac dysfunction was associated with worse elevation of liver enzymes. We found a graded increase in mean levels of maximal ALT, first and maximal ALP, and first and maximal GGT values. Using propensity score matching to estimate the impact of cardiac dysfunction on liver injury, we chose patients with the worst cardiac function parameters: (LVEF &lt; 45% and CVP &gt;10 mm\/Hg; n = 61) and compared them to matched patients with better cardiac function (n = 45). We found a significantly higher level of maximal ALT, first and maximal ALP, and GGT values in the group with the worst cardiac function parameters (p &lt; 0.05). Conclusions: Among patients with STEMI, the combination of decreased LVEF and venous congestion was associated with liver enzymes elevation suggesting a possible cardio-hepatic syndrome.<\/jats:p>","DOI":"10.3390\/jpm11121241","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T01:43:22Z","timestamp":1638323002000},"page":"1241","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The Cardio-Hepatic Relation in STEMI"],"prefix":"10.3390","volume":"11","author":[{"given":"Lian","family":"Bannon","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tel Aviv Sourasky Medical Center, Tel Aviv 64239, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3294-5968","authenticated-orcid":false,"given":"Ilan","family":"Merdler","sequence":"additional","affiliation":[{"name":"Cardiology Department, Tel Aviv Sourasky Medical Center, Tel Aviv 64239, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"Bar","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tel Aviv Sourasky Medical Center, Tel Aviv 64239, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4873-2887","authenticated-orcid":false,"given":"Lior","family":"Lupu","sequence":"additional","affiliation":[{"name":"Cardiology Department, Tel Aviv Sourasky Medical Center, Tel Aviv 64239, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shmuel","family":"Banai","sequence":"additional","affiliation":[{"name":"Cardiology Department, Tel Aviv Sourasky Medical Center, Tel Aviv 64239, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giris","family":"Jacob","sequence":"additional","affiliation":[{"name":"Internal Medicine F, Tel Aviv Sourasky Medical Center, Tel Aviv 64239, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yacov","family":"Shacham","sequence":"additional","affiliation":[{"name":"Cardiology Department, Tel Aviv Sourasky Medical Center, Tel Aviv 64239, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4254\/wjh.v6.i1.41","article-title":"Hepato-cardiac disorders","volume":"6","author":"Fouad","year":"2014","journal-title":"World J. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-0031-1284434","article-title":"Liver Abnormalities in Cardiac Diseases and Heart Failure","volume":"20","author":"Alvarez","year":"2011","journal-title":"Int. J. Angiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/hep.1840070527","article-title":"Conceptual review of the hepatic vascular bed","volume":"7","author":"Lautt","year":"1987","journal-title":"Hepatology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.5152\/tjg.2015.0086","article-title":"How to interpret liver function tests in heart failure patients?","volume":"26","author":"Cagli","year":"2020","journal-title":"Turk. J. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/cld.573","article-title":"Congestive hepatopathy","volume":"8","author":"Hilscher","year":"2016","journal-title":"Clin. Liver Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/hep.25692","article-title":"Congenital heart disease and the liver","volume":"56","author":"Asrani","year":"2012","journal-title":"Hepatology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12872-017-0485-6","article-title":"Association of serum transaminases with short-and long-term out-comes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"17","author":"Gao","year":"2017","journal-title":"BMC Cardiovasc. Disord."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Oh, P.C., Eom, Y.S., Moon, J., Jang, H.-J., Kim, T.-H., Suh, J., Kong, M.G., Park, S.-D., Kwon, S.W., and Choe, J.Y. (2020). Prognostic impact of the combination of serum transaminase and alkaline phosphatase determined in the emergency room in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0233286"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ijcard.2014.09.002","article-title":"Serum transaminase determined in the emergency room predicts outcomes in patients with acute ST-segment elevation myocardial infarction who undergo primary percutaneous coronary intervention","volume":"177","author":"Moon","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/eci.12655","article-title":"Liver and cholestatic pa-rameters as prognostic biomarkers of in-hospital MACE in patients with STEMI","volume":"46","author":"Huseynov","year":"2016","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e11393","DOI":"10.1097\/MD.0000000000011393","article-title":"Serum gamma-glutamyl transferase is a predictor of mortality in patients with acute myocardial infarction","volume":"97","author":"Kim","year":"2018","journal-title":"Medicine"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary: A Report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"Kushner","year":"2013","journal-title":"Am. Coll. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.echo.2017.09.007","article-title":"Abnor-mal coronary flow velocity reserve and decreased myocardial contractile reserve are main factors in relation to physical exer-cise capacity in cardiac amyloidosis","volume":"31","author":"Clemmensen","year":"2018","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","article-title":"Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology","volume":"18","author":"Lang","year":"2005","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/01.CIR.93.6.1160","article-title":"Relation of Mean Right Atrial Pressure to Echocardiographic and Doppler Parameters of Right Atrial and Right Ventricular Function","volume":"93","author":"Nagueh","year":"1996","journal-title":"Circle"},{"key":"ref_16","first-page":"320","article-title":"Correlation between inferior vena cava diameter and central venous pressure in critically ill patients","volume":"95","author":"Wiwatworapan","year":"2012","journal-title":"J. Med. Assoc. Thail."},{"key":"ref_17","first-page":"1","article-title":"Hepatic circulation: Physiology and pathophysiology","volume":"1","author":"Lautt","year":"2009","journal-title":"Colloquium Series on Integrated Systems Physiology: From Molecule to Function"},{"key":"ref_18","first-page":"711","article-title":"XXIX. The anatomy and physiology of the liver","volume":"123","author":"Kiernan","year":"1833","journal-title":"Philos. Trans. R. Soc. Lond."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/hrt.13.3.273","article-title":"The Liver in Heart Failure Relation of Anatomical, Functional, and Circulatory Changes","volume":"13","author":"Sherlock","year":"1951","journal-title":"Heart"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2010.09.010","article-title":"Cardiovascular Diseases and the Liver","volume":"15","author":"Weisberg","year":"2011","journal-title":"Clin. Liver Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1067\/mhj.2000.107177","article-title":"Heart diseases affecting the liver and liver diseases affecting the heart","volume":"140","author":"Naschitz","year":"2000","journal-title":"Am. Hear. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.jacc.2013.03.042","article-title":"Cardiohepatic interactions in heart failure: An overview and clinical implications","volume":"61","author":"Samsky","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/eurheartj\/ehs332","article-title":"Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure","volume":"34","author":"Nikolaou","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ejim.2012.11.009","article-title":"Concomitant renal and hepatic dysfunctions in chronic heart failure: Clinical implications and prognostic significance","volume":"24","author":"Poelzl","year":"2013","journal-title":"Eur. J. Intern. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/heart.87.1.9","article-title":"Cirrhotic cardiomyopathy: A pathophysiological review of circulatory dysfunction in liver disease","volume":"87","author":"Henriksen","year":"2002","journal-title":"Heart"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/liv.13589","article-title":"The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis","volume":"38","author":"Bendtsen","year":"2018","journal-title":"Liver Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/liv.12187","article-title":"Systolic and diastolic dysfunction in cirrhosis: A tissue-Doppler and speckle tracking echocardiography study","volume":"33","author":"Sampaio","year":"2013","journal-title":"Liver Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/hep.26509","article-title":"Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension, and a normal creatinine","volume":"58","author":"Serradilla","year":"2013","journal-title":"Hepatology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/hep.21640","article-title":"Elevated troponin I levels in acute liver fail-ure: Is myocardial injury an integral part of acute liver failure?","volume":"45","author":"Parekh","year":"2007","journal-title":"Hepatology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/01.shk.0000132484.97424.32","article-title":"Cardiac troponin I levels are a risk factor for mor-tality and multiple organ failure in noncardiac critically ill patients and have an additive effect to the APACHE II score in outcome prediction","volume":"22","author":"Wu","year":"2004","journal-title":"Shock"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/MCA.0b013e32834e4ef1","article-title":"Pattern of liver enzyme elevations in acute ST-elevation myocardial infarction","volume":"23","author":"Lofthus","year":"2012","journal-title":"Coron. Artery Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ijcard.2014.08.103","article-title":"Clinical and prognostic significance of increased liver en-zymes in ST-elevation myocardial infarction","volume":"177","author":"Lazzeri","year":"2014","journal-title":"Int. J. Cardiol."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/12\/1241\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:34:34Z","timestamp":1760168074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/12\/1241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,23]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["jpm11121241"],"URL":"https:\/\/doi.org\/10.3390\/jpm11121241","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,23]]}}}